C12N 2720/12352
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2720/12352 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 10
- Inventors
- 47
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant expression platform, constructs and methods for expression of difficult to express proteins (DTE-PS)24 Feb 2026US 12,559,761 B2Premas Biotech Pvt Ltd
- Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine9 Apr 2024US 11,952,400 B2Tecon Biopharmaceutical Co., Ltd.
- Method for in-vitro preparation of double-layered virus-like particles of rotavirus9 Jan 2018US 9,862,933 B2Xiamen Innovax Biotech Co., Ltd.
- Method for preparing reassortant rotavirus13 Nov 2025US 2025/0346867 A1
- Method for producing reassortant reoviridae virus, and vector library for same19 Sep 2024US 2024/0309336 A1SK Bioscience Co., Ltd.
- Rotavirus vectors for heterologous gene delivery20 Jun 2024US 2024/0200099 A1Merck Sharp & Dohme Corp.
- Immunogenic composition useful for vaccination against rotavirus15 Feb 2024US 2024/0050555 A1Boehringer Ingelheim Vetmedica GmbH
- Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps)30 Mar 2023US 2023/0097374 A1Premas Biotech Pvt Ltd
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.